Closing the gaps in hormonal healthcare with Sylvia Kang from Mira
Sep 10, 2024
auto_awesome
Sylvia Kang, CEO and co-founder of Mira, a home hormonal testing company, sheds light on the critical gaps in women's hormonal healthcare. She discusses the lack of research and funding for women's health startups and the importance of FDA approval. The conversation highlights how the pandemic increased demand for remote monitoring and how AI is revolutionizing hormonal health insights. Sylvia also dives into the complexities of balancing affordability and effectiveness in fertility treatments while navigating the challenges of innovation in women's health.
Mira addresses the critical lack of research in women's hormonal health by providing at-home testing and data-driven insights for better fertility management.
The podcast emphasizes the challenges of fundraising for women’s health startups and the importance of integrating innovations into mainstream healthcare systems.
Deep dives
Importance of Hormonal Health Data
Research on women's hormonal health is severely lacking, creating challenges for women facing fertility issues. Without continuous tracking data, medical professionals often rely on guesswork to diagnose and treat problems related to hormonal fluctuations. This gap in research leads to women being thrown directly into costly infertility treatments, such as IVF, with low success rates, instead of receiving personalized care based on individual hormone data. There is a critical need for more focus on women's health research to enable better treatment and understanding of fertility and hormonal issues.
Innovative Home Hormonal Testing
Mira offers an innovative solution to these challenges through its at-home hormonal testing system. The Mira Monitor allows users to test multiple key hormones using urine samples without the need for invasive blood tests. This technology delivers quantitative readings similar to laboratory tests, enabling women to track their hormonal levels and understand their fertility cycles more accurately. The accompanying app provides users with insights into their hormonal health, helping them identify conditions like PCOS or issues related to egg quality.
Shifting Perspectives in Women's Health
The launch of Mira coincided with a growing awareness of women's health issues, driven by societal trends and increased maternal age among women. Women are delaying family planning to focus on careers, which has led to a surge in fertility challenges and a demand for better awareness and tools available for reproductive health. Investors and stakeholders are increasingly recognizing the importance of these innovations, resulting in a more supportive environment for companies dedicated to women's health. Despite progress, there remain hurdles in securing funding and overcoming skepticism from those in the medical community.
Leveraging Data and AI for Better Outcomes
Mira's use of data analytics and AI plays a crucial role in providing personalized recommendations based on hormone testing results. By gathering extensive hormonal data from users, the company can identify patterns and tailor advice for individual users to improve their reproductive health. This commitment to understanding users' hormonal profiles aims to empower women with actionable insights that can help them in their family planning journey. As the company expands, it seeks to collaborate with healthcare providers to integrate their findings into broader healthcare systems, enhancing the medical industry's understanding of women's health.
Research is completely lacking when it comes to information about women’s hormonal health. Today’s guest is working to compile data and help women find the care they need. This week on Found, we’re talking to Sylvia Kang, the CEO and co-founder of Mira, a women’s health company that is providing home hormonal testing. They discuss the challenges on fundraising for women’s health startups, the importance of research to drive change and access in healthcare, and how Mira forged a new path by becoming FDA approved.
00:00 - Introduction and Overview of Women’s Hormonal Health 01:45 - The Lack of Hormonal Health Data and Fertility Challenges 05:11 - The Inspiration Behind Starting Mira 07:30 - Early Feedback from Doctors and Investors 10:58 - The Evolution of the Women’s Health Market 13:25 - Overcoming the Lack of Scientific Research and Data Collection 16:51 - Impact of COVID-19 on Mira’s Growth 18:42 - Mira as a Cost-Effective Solution to Fertility Issues 21:29 - Mira’s Expansion Beyond Fertility and into IVF 25:02 - Utilizing AI to Personalize Hormonal Health Tracking 28:35 - Sylvia’s Journey from Corporate to Entrepreneurship 32:15 - Building a Female-Driven Company Culture at Mira 34:49 - The Future of Women’s Health and Expanding Mira’s Impact